companydata.dkcompanydata.dk

Proxi Biotech ApS: Financial statements 2023

CVR: 39859211

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

Proxi Biotech ApS (CVR 39859211) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 520,824 and a net result of DKK 68,661 compared with DKK -72,371 the year before. That is an increase of 26.7% compared with the year before. Equity in the 2023 report amounted to DKK -9,896. The company had 1 employee in the financial year.

Gross Profit
DKK 520,824
Profit/Loss
DKK 68,661
Equity
DKK -9,896
Total Assets
DKK 219,314
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-521 t.69 t.-10 t.1
2022-411 t.-72 t.-79 t.1
2021-461 t.2 t.-6 t.1
2020-337 t.85 t.-9 t.1
2019-176 t.-94 t.-93 t.0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Proxi Biotech ApS: The 2022 annual report is outMay 30, 2023

Proxi Biotech ApS has published its annual report for 2022. Gross profit came to DKK 411,123, and the net result was DKK -72,371.

About Proxi Biotech ApS

Proxi Biotech ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named PrOxi Biotech ApS and PrOxi Biotech IVS. The management consists of Rene Jørgensen and Aria Aminzadeh. The board consists of Sten Verland (chair), Aria Aminzadeh, Paul Jefferson Hargreaves and Per Bo Pedersen Fischer. The company is owned by Aminzadeh Holding ApS, Dr RJ Holding ApS and Century House Holding ApS. The company has 6 employees (2026). In 2025, the company reported a gross profit of DKK -430,820 and a net result of DKK -1,688,504 compared with DKK 426,762 the year before. Equity in the 2025 report amounted to DKK -1,712,625.

Source: annual report 2025, Danish Business Authority

Other financial years